Related Experiment Video
Updated: May 31, 2026
12:17
Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells
Published on: January 2, 2016
Cyclic nucleotides and phosphodiesterases in monocytic differentiation
Angie L Hertz1, Joseph A Beavo
1Department of Pharmacology, School of Medicine, University of Washington, 357280, Seattle, WA 98125, USA. alhertz@uw.edu
Handbook of Experimental Pharmacology
|June 23, 2011
Summary
Inhibiting phosphodiesterases (PDEs) alters cyclic nucleotide levels, impacting how monocytes differentiate into macrophages, dendritic cells, and osteoclasts. This modulation affects cell phenotypes and differentiation pathways.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Monocytes are versatile immune cells capable of differentiating into various cell types like macrophages, dendritic cells, and osteoclasts.
- Cell differentiation is influenced by cytokines and intracellular cyclic nucleotides, specifically 3'-5'-cyclic adenosine monophosphate (cAMP) and 3'-5'-cyclic guanosine monophosphate (cGMP).
- Cyclic nucleotide levels are regulated by synthesis (adenylyl and guanylyl cyclases) and degradation (phosphodiesterases, PDEs).
Purpose of the Study:
- To explore the impact of phosphodiesterase (PDE) inhibition on monocytic differentiation.
- To investigate how elevated cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels affect monocyte-derived cell phenotypes.
- To understand the influence of PDE inhibition on the differentiation process into osteoclasts, dendritic cells, and macrophages.
Main Methods:
- Utilizing phosphodiesterase (PDE) inhibitors to modulate intracellular cyclic nucleotide levels.
- Analyzing changes in monocyte differentiation pathways.
- Assessing phenotypic alterations in differentiated cells, including surface marker expression, gene expression, and cytokine/chemokine secretion.
Main Results:
- Phosphodiesterase (PDE) inhibition leads to altered cyclic nucleotide (cAMP and cGMP) levels.
- Changes in cyclic nucleotide levels modify the phenotype of differentiating monocytes, affecting surface markers and gene expression.
- The differentiation process can be either inhibited or enhanced by PDE inhibition, depending on the specific cell type and timing of intervention.
Conclusions:
- Phosphodiesterase (PDE) inhibition is a key regulator of monocyte differentiation.
- Modulating cyclic nucleotide (cAMP and cGMP) levels through PDE inhibition offers a mechanism to control the development of macrophages, dendritic cells, and osteoclasts.
- Understanding these pathways provides insights into cellular immunology and potential therapeutic strategies.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...